Navigation Links
France-Israel scientific cooperation agreement
Date:3/16/2009

Jerusalem, March 16, 2009 A French-Israeli scientific agreement, known as the European Associated Laboratory Agreement (LEA), will be signed at the Hebrew University of Jerusalem on Wednesday, March 18, within the framework of the France-Israel Binational Symposium in Neuroscience.

The new agreement marks the renewal of a 2004 joint project known as the France-Israel International Associated Laboratory Agreement, which established the Franco-Israeli Laboratory of System Neurophysiology and Neurophysics, bringing together French and Israeli researchers. The French members, from the French National Research Center (CNRS), are faculty members of Paris-Descartes University and Victor Segalen University in Bordeaux, while the Israeli researchers are senior scientists at the Hebrew University of Jerusalem.

That cooperative effort led to several collaborative joint research projects between scientists in the two countries, as well as to the first-ever French-Israeli binational neuroscience symposium -- first held in Israel in 2004 and now taking place biannually -- and to joint scientific publications.

The new agreement establishing the European Associated Laboratory (LEA), entitled the France-Israel Laboratory of Neuroscience, will be signed in the presence of President of the Hebrew University Prof. Menachem Magidor, Vice-President of the Hebrew University for Research and Development Prof. Hillel Bercovier, President of the CNRS Prof. Catherine Brechignac, and Vice-President of the Victor Segalen University Prof. Alain Blanchard. The ceremony will be held at 8:30 a.m. at the Belgium House Faculty Club on the Edmond J. Safra Campus of the Hebrew University at Givat Ram. .

"Ties with the French scientific world and especially with the large research institutions in Europe create new opportunities in brain research," said Prof. Israel Nelken of the Silberman Institute of Life Sciences at the Hebrew University and one of the leaders of the joint project. "This cooperation is especially significant in a period during which one hears voices in Europe calling for a boycott of Israeli academia."

The March 18 France-Israel Symposium in Neuroscience, to follow the agreement signing, will be held at the Konrad Adenauer Center at Mishkenot Shaananim starting at 2:15 p.m. and will feature presentations on a range of recent joint French-Israeli studies as well as topics of research and collaboration planned for coming years. The symposium is open to students and researchers who are not members of the LEA as well as members of the media.

Sponsors of the event are the France-Israel Laboratory of Neuroscience and the French Ministry of Foreign Affairs. The program will begin with remarks by Profs. l Nelken of the Hebrew University and David Hansel of the University of Paris Descartes, co-directors of the LEA, and will continue until 7:30 p.m.


'/>"/>
Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert

Related medicine news :

1. ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board
2. MedThink Hires Associate Scientific Director to Support Its Growing Health Care Clientele
3. Boston Scientific to Participate in Cowen Health Care Conference
4. IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs
5. Boston Scientific Welcomes Committee Approval of the National Pain Care Policy Act
6. Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
7. Boston Scientific Announces Election Of John Sununu To Its Board Of Directors
8. Traxtal to Introduce Next-Generation PercuNav System Cart at SIR Annual Scientific Meeting
9. Edmond Scientific Company Awarded VA Contract for External Integration Architecture Support
10. Society of Interventional Radiology Hosts 34th Annual Scientific Meeting
11. Avantis Medical Systems Announces Key Addition to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... , ... Journal of Oral Implantology – Tooth loss is not ... health, including complications with speech, eating, and overcompensation of mouth due to the deficiency. ... As the number of tooth replacements increase, it is imperative to design an implant ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete ... has been honored by Enterprising Women magazine as one of its 2017 Enterprising ... women business owners. Winners have demonstrated that they have fast-growth businesses, mentor or ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... RawTrition now ... easy way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients ... the cellular level because the body recognizes its raw form (unlike the synthetically made ...
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Global Surgical Drainage Device Market: Overview ... to remove excess liquid and air. The fluid to ... or lymph. Surgical drains are used in a wide ... surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common use ... accumulation of fluid e.g. blood or pus. Surgical drains ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... April 19, 2017  SARES•REGIS Group leased the ... developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company developing ... diseases that have been underserved by scientific innovation, ... for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: